UNSPSC 41141803: Bilirubin

In this classification, this entry connotes a substrate made of Bilirubin that is used in clinical chemistry testing.

UNSPSC 41141803 Bilirubin is a Commodity code that does not reflect the actual scope of work state and local governments are acquiring under this classification. Recent solicitations posted by state and local agencies show little relevant activity tied to bilirubin as a standalone diagnostic reagent. Instead, the opportunities tagged to this code encompass a much broader range of laboratory consumables, reagents, culture media, extraction supplies, and quality-control materials used in clinical diagnostics, environmental testing, food and water safety analysis, and genomic sequencing operations. The issuing bodies include state health departments (Texas Health and Human Services Commission, Mississippi State Department of Health), county governments (Gwinnett County, Georgia), cities (Philadelphia), universities (University of Texas Health Science Center at San Antonio), and regional public health laboratories. The geographic spread covers Texas, Georgia, Mississippi, and Pennsylvania, with Texas appearing most active in recent months across multiple solicitations for laboratory supplies and consumables.

Representative recent opportunities include the Texas Health and Human Services Commission issuing IFB HHS0017881 on August 19, 2026, for laboratory supplies for food, water, dairy, and shellfish testing compatible with Biomerieux instruments, with responses due August 26, 2026, and a historical annual value between $25,000 and $50,000; the Mississippi State Department of Health posting a sole-source notice on April 28, 2026, for Illumina kits and reagents supporting whole genome sequencing operations at an estimated cost of $393,667.98; and the University of Texas Health Science Center at San Antonio conducting an RFP (745-26-P19) with a June 4, 2026, deadline for a comprehensive biotech research, clinical diagnostics, and equipment catalog spanning antibodies, chromatography systems, genomics reagents, and immunoassay kits. The code shows mismatch between its nominal scope and actual procurement activity, suggesting limited direct sourcing for bilirubin specifically and instead capturing miscoded or broadly tagged laboratory supply acquisitions.